首页 > 最新文献

EMC - Gynécologie-Obstétrique最新文献

英文 中文
Myomectomies par laparotomie 剖腹肌切除术
Pub Date : 2005-11-01 DOI: 10.1016/j.emcgo.2005.08.001
H. Foulot (Praticien hospitalier) , N. Chopin (Chef de clinique-assistant) , C. Malartic (Chef de clinique-assistant) , A. Fauconnier (Praticien hospitalier) , C. Chapron (Professeur agrégé)

Laparotomic abdominal myomectomy is a procedure undertaken essentially in child-bearing women with symptomatic myomas and who may not benefit from hysteroscopic or coelioscopic surgery. Such interventions may have peroperative complications such as important blood loss necessitating blood transfusion, or postoperative complications such as postoperative adherences. This underlines the importance of a preoperative assessment aimed at obtaining the best evaluation of the risks and benefits related to such intervention.

腹部子宫肌瘤切除术主要用于有症状的子宫肌瘤的育龄妇女,这些妇女可能无法从宫腔镜或腹腔镜手术中获益。这种干预措施可能有术中并发症,如大量失血而需要输血,或术后并发症,如术后粘连。这强调了术前评估的重要性,目的是获得与这种干预有关的风险和益处的最佳评估。
{"title":"Myomectomies par laparotomie","authors":"H. Foulot (Praticien hospitalier) ,&nbsp;N. Chopin (Chef de clinique-assistant) ,&nbsp;C. Malartic (Chef de clinique-assistant) ,&nbsp;A. Fauconnier (Praticien hospitalier) ,&nbsp;C. Chapron (Professeur agrégé)","doi":"10.1016/j.emcgo.2005.08.001","DOIUrl":"https://doi.org/10.1016/j.emcgo.2005.08.001","url":null,"abstract":"<div><p>Laparotomic abdominal myomectomy is a procedure undertaken essentially in child-bearing women with symptomatic myomas and who may not benefit from hysteroscopic or coelioscopic surgery. Such interventions may have peroperative complications such as important blood loss necessitating blood transfusion, or postoperative complications such as postoperative adherences. This underlines the importance of a preoperative assessment aimed at obtaining the best evaluation of the risks and benefits related to such intervention.</p></div>","PeriodicalId":100424,"journal":{"name":"EMC - Gynécologie-Obstétrique","volume":"2 4","pages":"Pages 377-383"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcgo.2005.08.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91632181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Technique des lymphadénectomies pelviennes laparoscopiques 腹腔镜盆腔淋巴结切除术技术
Pub Date : 2005-11-01 DOI: 10.1016/J.EMCGO.2005.07.008
É. Leblanc, D. Querleu, F. Narducci, G. Cartron
{"title":"Technique des lymphadénectomies pelviennes laparoscopiques","authors":"É. Leblanc, D. Querleu, F. Narducci, G. Cartron","doi":"10.1016/J.EMCGO.2005.07.008","DOIUrl":"https://doi.org/10.1016/J.EMCGO.2005.07.008","url":null,"abstract":"","PeriodicalId":100424,"journal":{"name":"EMC - Gynécologie-Obstétrique","volume":"1 1","pages":"401-408"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72926629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Grossesse après transplantation hépatique 肝移植后怀孕
Pub Date : 2005-11-01 DOI: 10.1016/j.emcgo.2005.08.003
V. Houfflin Debarge , S. Dharancy , A. Bourgain , A.-F. Dalmas , J.-P. Dubos , F.-R. Pruvot

Pregnancy is possible for women after liver transplantation. However, these women have a higher risk of pre eclampsia, hypertension, small for gestational age and preterm delivery than the normal obstetric population. Pregnancy can be safely considered one year after the transplantation provided hepatic and renal functions are stable. Renal dysfunction is associated with a higher risk of foetal and maternal complication. Immunosuppressive medication should be continued. Pregnancy does not appear to alter hepatic graft function. Careful monitoring of these pregnancies is essential for favourable outcome.

肝移植后的女性有可能怀孕。然而,这些妇女患先兆子痫、高血压、小于胎龄和早产的风险高于正常产科人群。如果肝肾功能稳定,移植后一年可以考虑怀孕。肾功能不全与胎儿和母体并发症的高风险相关。应继续使用免疫抑制药物。妊娠似乎不会改变肝移植的功能。仔细监测这些妊娠对于获得良好的结局至关重要。
{"title":"Grossesse après transplantation hépatique","authors":"V. Houfflin Debarge ,&nbsp;S. Dharancy ,&nbsp;A. Bourgain ,&nbsp;A.-F. Dalmas ,&nbsp;J.-P. Dubos ,&nbsp;F.-R. Pruvot","doi":"10.1016/j.emcgo.2005.08.003","DOIUrl":"10.1016/j.emcgo.2005.08.003","url":null,"abstract":"<div><p>Pregnancy is possible for women after liver transplantation. However, these women have a higher risk of pre eclampsia, hypertension, small for gestational age and preterm delivery than the normal obstetric population. Pregnancy can be safely considered one year after the transplantation provided hepatic and renal functions are stable. Renal dysfunction is associated with a higher risk of foetal and maternal complication. Immunosuppressive medication should be continued. Pregnancy does not appear to alter hepatic graft function. Careful monitoring of these pregnancies is essential for favourable outcome.</p></div>","PeriodicalId":100424,"journal":{"name":"EMC - Gynécologie-Obstétrique","volume":"2 4","pages":"Pages 364-370"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcgo.2005.08.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77780157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myomectomies par laparotomie 剖腹肌切除术
Pub Date : 2005-11-01 DOI: 10.1016/J.EMCGO.2005.08.001
H. Foulot, N. Chopin, C. Malartic, A. Fauconnier, C. Chapron
{"title":"Myomectomies par laparotomie","authors":"H. Foulot, N. Chopin, C. Malartic, A. Fauconnier, C. Chapron","doi":"10.1016/J.EMCGO.2005.08.001","DOIUrl":"https://doi.org/10.1016/J.EMCGO.2005.08.001","url":null,"abstract":"","PeriodicalId":100424,"journal":{"name":"EMC - Gynécologie-Obstétrique","volume":"49 2 1","pages":"377-383"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89607988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Accouchement du prématuré 早产儿的分娩
Pub Date : 2005-11-01 DOI: 10.1016/j.emcgo.2005.09.001
V. Castaigne, O. Picone, R. Frydman

Spontaneous or induced prematurity are leading causes of perinatal morbidity and mortality. Gestational age is the more important prognosis factor. Prevention and management of preterm labour are fundamental. Improvement of morbidity and mortality can be achieved by antenatal corticosteroid therapy and delivery in a maternity hospital adapted to the gestational age. The mode of delivery of premature infants is controversial. However, natural delivery seems to be privileged in case of vertex presentation. In breech presentation or in case of chorioamnionitis, caesarean section is preferred.

自发性或诱发性早产是围产期发病和死亡的主要原因。胎龄是更重要的预后因素。预防和管理早产是根本。通过产前皮质类固醇治疗和在适合胎龄的妇产医院分娩,可以改善发病率和死亡率。早产婴儿的分娩方式存在争议。然而,在顶点表示的情况下,自然传递似乎是优先的。在臀位或绒毛膜羊膜炎的情况下,剖腹产是首选。
{"title":"Accouchement du prématuré","authors":"V. Castaigne,&nbsp;O. Picone,&nbsp;R. Frydman","doi":"10.1016/j.emcgo.2005.09.001","DOIUrl":"https://doi.org/10.1016/j.emcgo.2005.09.001","url":null,"abstract":"<div><p>Spontaneous or induced prematurity are leading causes of perinatal morbidity and mortality. Gestational age is the more important prognosis factor. Prevention and management of preterm labour are fundamental. Improvement of morbidity and mortality can be achieved by antenatal corticosteroid therapy and delivery in a maternity hospital adapted to the gestational age. The mode of delivery of premature infants is controversial. However, natural delivery seems to be privileged in case of vertex presentation. In breech presentation or in case of chorioamnionitis, caesarean section is preferred.</p></div>","PeriodicalId":100424,"journal":{"name":"EMC - Gynécologie-Obstétrique","volume":"2 4","pages":"Pages 354-363"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcgo.2005.09.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136975804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Index des auteurs 作者索引
Pub Date : 2005-11-01 DOI: 10.1016/S1762-6145(05)00029-6
{"title":"Index des auteurs","authors":"","doi":"10.1016/S1762-6145(05)00029-6","DOIUrl":"https://doi.org/10.1016/S1762-6145(05)00029-6","url":null,"abstract":"","PeriodicalId":100424,"journal":{"name":"EMC - Gynécologie-Obstétrique","volume":"2 4","pages":"Page 422"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1762-6145(05)00029-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91632182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Traitement médicamenteux de l'endométriose (adénomyose exclue) 子宫内膜异位症(子宫内膜异位症除外)的药物治疗
Pub Date : 2005-11-01 DOI: 10.1016/j.emcgo.2005.08.002
C. Azoulay , E. Daraï

Endometriosis is a common condition often underestimated because of a tricky clinical diagnosis. Most frequent clinical presentations (dysmenorrhoea, dyspareunia, chronic pelvic pain) are very evocative if increased during menstruations. Endometriosis can also be revealed by urinary (dysuria, pollakiuria) or digestive (dyschezia, menstrual proctorrhagias, transit dysfunction) symptoms. Non-steroid anti-inflammatory drugs can be used as first-line medical treatment for sole dysmenorrhoea when the patient does not need contraception. In teenagers or very young women, provided there is no contraindication, estroprogestative oral contraception can be considered as alternative treatment. When symptoms are more severe or noncyclic, progestins chosen in 17α-hydroxy- or 19-Nor-progesterone-derivatives should be the first choice regarding their effectiveness, their low cost and their long-term good tolerance. GnRH agonists should only be considered when adequate pain relief is not obtained from the other treatment options or, for some authors, as a pre-operative therapy. For long-term treatment by GnRH agonist, hormone therapy should be associated to limit treatment side effects.

子宫内膜异位症是一种常见的疾病,由于临床诊断困难,常常被低估。最常见的临床表现(痛经,性交困难,慢性盆腔疼痛)是非常唤起,如果在月经期间增加。子宫内膜异位症也可表现为泌尿系统(排尿困难、尿漏)或消化系统(排尿困难、月经前出血、转运功能障碍)症状。当患者不需要避孕时,非甾体类抗炎药可作为足底痛经的一线药物治疗。在青少年或非常年轻的妇女中,如果没有禁忌症,可以考虑口服雌激素避孕药作为替代治疗。当症状较严重或非周期时,应优先选择17α-羟基或19-非黄体酮衍生物,因为其疗效好、成本低、长期耐受性好。只有当不能从其他治疗方案中获得足够的疼痛缓解时,或者对一些作者来说,作为术前治疗,才应该考虑使用GnRH激动剂。对于GnRH激动剂的长期治疗,应结合激素治疗以限制治疗副作用。
{"title":"Traitement médicamenteux de l'endométriose (adénomyose exclue)","authors":"C. Azoulay ,&nbsp;E. Daraï","doi":"10.1016/j.emcgo.2005.08.002","DOIUrl":"10.1016/j.emcgo.2005.08.002","url":null,"abstract":"<div><p>Endometriosis is a common condition often underestimated because of a tricky clinical diagnosis. Most frequent clinical presentations (dysmenorrhoea, dyspareunia, chronic pelvic pain) are very evocative if increased during menstruations. Endometriosis can also be revealed by urinary (dysuria, pollakiuria) or digestive (dyschezia, menstrual proctorrhagias, transit dysfunction) symptoms. Non-steroid anti-inflammatory drugs can be used as first-line medical treatment for sole dysmenorrhoea when the patient does not need contraception. In teenagers or very young women, provided there is no contraindication, estroprogestative oral contraception can be considered as alternative treatment. When symptoms are more severe or noncyclic, progestins chosen in 17α-hydroxy- or 19-Nor-progesterone-derivatives should be the first choice regarding their effectiveness, their low cost and their long-term good tolerance. GnRH agonists should only be considered when adequate pain relief is not obtained from the other treatment options or, for some authors, as a pre-operative therapy. For long-term treatment by GnRH agonist, hormone therapy should be associated to limit treatment side effects.</p></div>","PeriodicalId":100424,"journal":{"name":"EMC - Gynécologie-Obstétrique","volume":"2 4","pages":"Pages 312-328"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcgo.2005.08.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82491441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Myomectomies : prévention de l'hémorragie 肌瘤切除术:预防出血
Pub Date : 2005-11-01 DOI: 10.1016/j.emcgo.2005.08.004
C. Davitian (Chef de clinique-assistant), G. Ducarme (Chef de clinique-assistant), A.-B. Rodrigues (Praticien hospitalier), A. Tigaizin (Chef de clinique-assistant), H. Dauphin (Chef de clinique-assistant), M. Benchimol (Chef de clinique-assistant), N. Seince (Praticien hospitalier), M. Uzan (Professeur des Universités, praticien hospitalier), C. Poncelet (Maître de conférences des Universités, praticien hospitalier)

Myomectomy is a surgical procedure that allows preservation of the uterus in case of myomatous disease. Various surgical approaches may be considered. However, abundant peroperative haemorrhage may occur, resulting in complications such as incomplete surgery, modification of the surgical access, hypovolaemic shock, blood transfusion, and severe postoperative anaemia, necessitating aggressive treatment and transfusion, and delaying activity recovery. Such observations justify in seeking for means able to prevent peroperative haemorrhage. Several medical preoperative means have been strictly evaluated. The preoperative usage of gonadotrophin releasing hormone (Gn-RH) agonists seems to result, after a reduction of the uterine volume by myometrium vascular re-arrangements, in a reduction of peroperative haemorrhage; the results are still debated. Administrations of Gn-RH, misoprostol or antiprogesterone seem promising but further studies are necessary to confirmation. Preoperative embolization of the myoma could reduce peroperative blood loss but the use of this procedure in childbearing women is under evaluation. Peroperative means are available: chemical means such as vasoconstrictive or oxytocic agents, and mechanical means which temporarily interrupt the myometrial blood flow. Some have shown efficacy. As alternatives to surgery, techniques such myolysis – which induces in situ myoma destruction – necessitate further research, particularly regarding young childbearing women.

子宫肌瘤切除术是一种在发生子宫肌瘤疾病时保留子宫的外科手术。可以考虑多种手术入路。然而,术中可能出现大量出血,导致手术不完全、手术通路改变、低血容量性休克、输血和术后严重贫血等并发症,需要积极治疗和输血,并延迟活动恢复。这些观察结果证明寻求能够预防术中出血的方法是合理的。一些医疗术前手段已经过严格评估。术前使用促性腺激素释放激素(Gn-RH)激动剂,在子宫肌层血管重新排列减少子宫体积后,似乎可以减少术中出血;结果仍有争议。Gn-RH、米索前列醇或抗黄体酮似乎很有希望,但需要进一步的研究来证实。术前栓塞肌瘤可以减少术中出血量,但在育龄妇女中使用这种方法还在评估中。可用的手术方法有:化学方法,如血管收缩剂或催产剂,和机械方法,暂时中断子宫肌血流量。其中一些已经显示出效果。作为手术的替代方案,诸如肌溶术(可诱发原位肌瘤破坏)等技术需要进一步研究,特别是对育龄妇女。
{"title":"Myomectomies : prévention de l'hémorragie","authors":"C. Davitian (Chef de clinique-assistant),&nbsp;G. Ducarme (Chef de clinique-assistant),&nbsp;A.-B. Rodrigues (Praticien hospitalier),&nbsp;A. Tigaizin (Chef de clinique-assistant),&nbsp;H. Dauphin (Chef de clinique-assistant),&nbsp;M. Benchimol (Chef de clinique-assistant),&nbsp;N. Seince (Praticien hospitalier),&nbsp;M. Uzan (Professeur des Universités, praticien hospitalier),&nbsp;C. Poncelet (Maître de conférences des Universités, praticien hospitalier)","doi":"10.1016/j.emcgo.2005.08.004","DOIUrl":"https://doi.org/10.1016/j.emcgo.2005.08.004","url":null,"abstract":"<div><p>Myomectomy is a surgical procedure that allows preservation of the uterus in case of myomatous disease. Various surgical approaches may be considered. However, abundant peroperative haemorrhage may occur, resulting in complications such as incomplete surgery, modification of the surgical access, hypovolaemic shock, blood transfusion, and severe postoperative anaemia, necessitating aggressive treatment and transfusion, and delaying activity recovery. Such observations justify in seeking for means able to prevent peroperative haemorrhage. Several medical preoperative means have been strictly evaluated. The preoperative usage of gonadotrophin releasing hormone (Gn-RH) agonists seems to result, after a reduction of the uterine volume by myometrium vascular re-arrangements, in a reduction of peroperative haemorrhage; the results are still debated. Administrations of Gn-RH, misoprostol or antiprogesterone seem promising but further studies are necessary to confirmation. Preoperative embolization of the myoma could reduce peroperative blood loss but the use of this procedure in childbearing women is under evaluation. Peroperative means are available: chemical means such as vasoconstrictive or oxytocic agents, and mechanical means which temporarily interrupt the myometrial blood flow. Some have shown efficacy. As alternatives to surgery, techniques such myolysis – which induces <em>in situ</em> myoma destruction – necessitate further research, particularly regarding young childbearing women.</p></div>","PeriodicalId":100424,"journal":{"name":"EMC - Gynécologie-Obstétrique","volume":"2 4","pages":"Pages 384-390"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcgo.2005.08.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91632178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diagnostic échographique des anomalies fœtales du premier trimestre de la grossesse (dépistage chromosomique par mesure de la clarté nucale exclue) 妊娠前三个月胎儿异常的超声诊断(不包括通过测量颈部清晰度进行染色体筛查)
Pub Date : 2005-11-01 DOI: 10.1016/j.emcgo.2005.09.003
E. Baulon (Chef de clinique-assistant des hôpitaux universitaires de Strasbourg) , M. Kohler (Praticien hospitalier) , C. Vayssière (Praticien hospitalier) , A. Kohler (Sage-femme) , M.-C. Hunsinger (Sage-femme) , M. Neumann (Sage-femme) , N. Buffet (Sage-femme) , M. Tanghe (Sage-femme) , C. Vayssière (Sage-femme) , C. Mager (Sage-femme) , R. Favre (Praticien hospitalier)

Complete anatomical survey of the foetus in the first trimester of pregnancy is possible, by transvaginal ultrasonography. Ideally, the ultrasonography should be performed between 12 and 14 weeks. At that time, a wide range of foetal congenital anomalies can be diagnosed, including defects of the central nervous system, heart, anterior abdominal wall, urinary tract, neck and skeleton. We studied 11,702 singleton pregnancies for which an ultrasonography was performed between 11 and 15 weeks at the Sonography and Foetal Medicine Unit of the CMCO in Schiltigheim/Strasbourg-France. We had a representative overview of the foetal abnormalities that could be observed in the first trimester, as most of these pregnancies were considered at high risk. 1313 abnormalities were suspected according to ultrasonographic examinations (11.2% of the studied population). Nuchal translucency, hygroma coli and Bonnevie-Ulrich syndrome were the most frequent abnormalities detected (more than 70%). Sensibility and specificity of the ultrasonographic investigations were evaluated. The first trimester ultrasonographic examination cannot detect all the malformations. However, it can detect the major ones and can define a high risk group that will need further assessment. It allows therefore early management. The anatomic ultrasonographic examination around 20 weeks gestation should also be performed, since a number of anomalies may not be evident at scanning during early pregnancy.

完整的解剖调查胎儿在怀孕的前三个月是可能的,经阴道超声检查。理想情况下,超声检查应在12至14周之间进行。那时,可以诊断的胎儿先天性异常范围很广,包括中枢神经系统、心脏、前腹壁、泌尿道、颈部和骨骼的缺陷。我们研究了11,702例单胎妊娠,这些妊娠在11至15周期间在法国Schiltigheim/Strasbourg-France的CMCO超声和胎儿医学部门进行超声检查。我们有一个代表性的概述胎儿畸形,可以观察到在前三个月,因为大多数怀孕被认为是高风险的。超声检查疑似异常1313例(占研究人群的11.2%)。颈透明、大肠湿肿和Bonnevie-Ulrich综合征是最常见的异常(超过70%)。评价超声检查的敏感性和特异性。妊娠早期超声检查不能发现所有的畸形。然而,它可以检测出主要的疾病,并可以确定需要进一步评估的高风险群体。因此,它允许早期管理。在妊娠20周左右也应该进行解剖超声检查,因为许多异常在妊娠早期扫描时可能不明显。
{"title":"Diagnostic échographique des anomalies fœtales du premier trimestre de la grossesse (dépistage chromosomique par mesure de la clarté nucale exclue)","authors":"E. Baulon (Chef de clinique-assistant des hôpitaux universitaires de Strasbourg) ,&nbsp;M. Kohler (Praticien hospitalier) ,&nbsp;C. Vayssière (Praticien hospitalier) ,&nbsp;A. Kohler (Sage-femme) ,&nbsp;M.-C. Hunsinger (Sage-femme) ,&nbsp;M. Neumann (Sage-femme) ,&nbsp;N. Buffet (Sage-femme) ,&nbsp;M. Tanghe (Sage-femme) ,&nbsp;C. Vayssière (Sage-femme) ,&nbsp;C. Mager (Sage-femme) ,&nbsp;R. Favre (Praticien hospitalier)","doi":"10.1016/j.emcgo.2005.09.003","DOIUrl":"10.1016/j.emcgo.2005.09.003","url":null,"abstract":"<div><p>Complete anatomical survey of the foetus in the first trimester of pregnancy is possible, by transvaginal ultrasonography. Ideally, the ultrasonography should be performed between 12 and 14 weeks. At that time, a wide range of foetal congenital anomalies can be diagnosed, including defects of the central nervous system, heart, anterior abdominal wall, urinary tract, neck and skeleton. We studied 11,702 singleton pregnancies for which an ultrasonography was performed between 11 and 15 weeks at the Sonography and Foetal Medicine Unit of the CMCO in Schiltigheim/Strasbourg-France. We had a representative overview of the foetal abnormalities that could be observed in the first trimester, as most of these pregnancies were considered at high risk. 1313 abnormalities were suspected according to ultrasonographic examinations (11.2% of the studied population). Nuchal translucency, hygroma coli and Bonnevie-Ulrich syndrome were the most frequent abnormalities detected (more than 70%). Sensibility and specificity of the ultrasonographic investigations were evaluated. The first trimester ultrasonographic examination cannot detect all the malformations. However, it can detect the major ones and can define a high risk group that will need further assessment. It allows therefore early management. The anatomic ultrasonographic examination around 20 weeks gestation should also be performed, since a number of anomalies may not be evident at scanning during early pregnancy.</p></div>","PeriodicalId":100424,"journal":{"name":"EMC - Gynécologie-Obstétrique","volume":"2 4","pages":"Pages 329-342"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcgo.2005.09.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84854766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Reconstruction mammaire différée par lambeau de grand dorsal 大背侧片延迟乳房重建
Pub Date : 2005-11-01 DOI: 10.1016/j.emcgo.2005.07.003
N. Bricout

The latissimus dorsi myocutaneous flap is a very versatile and reliable flap. It is probably the oldest myocutaneous flap known, used most commonly in reconstructive surgery. In breast reconstructive surgery, its versatility and safety allows many designs for cutaneous islands. It can also be used for autologous reconstructions, but most often implant is required. Raising the flap is neither a hard nor a long surgery; difficulties depend more on the choice of the fitted implant, (with the incidence of periprothetic contraction in case of radiotherapy) and on the surgery required on the other breast. For all these reasons, good expertise of breast plastic surgery is necessary.

背阔肌肌皮瓣是一种用途广泛、功能可靠的肌皮瓣。它可能是已知的最古老的肌皮瓣,最常用于重建手术。在乳房重建手术中,它的多功能性和安全性允许许多皮肤岛的设计。它也可以用于自体重建,但大多数情况下需要植入。抬高皮瓣既不困难也不耗时;困难更多地取决于植入物的选择(在放射治疗的情况下会发生假体周围收缩)和另一侧乳房所需的手术。由于这些原因,良好的乳房整形手术专业知识是必要的。
{"title":"Reconstruction mammaire différée par lambeau de grand dorsal","authors":"N. Bricout","doi":"10.1016/j.emcgo.2005.07.003","DOIUrl":"10.1016/j.emcgo.2005.07.003","url":null,"abstract":"<div><p>The latissimus dorsi myocutaneous flap is a very versatile and reliable flap. It is probably the oldest myocutaneous flap known, used most commonly in reconstructive surgery. In breast reconstructive surgery, its versatility and safety allows many designs for cutaneous islands. It can also be used for autologous reconstructions, but most often implant is required. Raising the flap is neither a hard nor a long surgery; difficulties depend more on the choice of the fitted implant, (with the incidence of periprothetic contraction in case of radiotherapy) and on the surgery required on the other breast. For all these reasons, good expertise of breast plastic surgery is necessary.</p></div>","PeriodicalId":100424,"journal":{"name":"EMC - Gynécologie-Obstétrique","volume":"2 4","pages":"Pages 409-421"},"PeriodicalIF":0.0,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcgo.2005.07.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87428092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
EMC - Gynécologie-Obstétrique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1